Exogenous amyloidogenic proteins function as seeds in amyloid β-protein aggregation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 4, 2014, Pages 646-653

  Ono, Kenjiro ^a   Takahashi, Ryoichi ^a   Ikeda, Tokuhei ^a,b   Mizuguchi, Mineyuki ^c   Hamaguchi, Tsuyoshi ^a   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b National Hospital Organization Iou National Hospital   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Seeding effect

Indexed keywords

ACTIN; AMYLIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PROTEIN; CASEIN; FIBROIN; SERICIN; THIOFLAVINE;

ARTICLE; BINDING SITE; CENTRAL NERVOUS SYSTEM; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; ULTRASOUND;

ALZHEIMER'S DISEASE; AMYLOID Β-PROTEIN; SEEDING EFFECT;

AMYLOID BETA-PEPTIDES; AMYLOIDOGENIC PROTEINS; AMYLOIDOSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON; THIAZOLES;

EID: 84893485687     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.01.002     Document Type: Article

References (41)

1. Jarrett J.T., Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993, 73:1055-1058.
2. Lomakin A., Chung D.S., Benedek G.B., Kirschner D.A., Teplow D.B. On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1125-1129.
3. Naiki H., Nakakuki K. First-order kinetic model of Alzheimer's β-amyloid fibril extension in vitro. Lab. Invest. 1996, 74:374-383.
4. Meyer-Luehmann M., Coomaraswamy J., Bolmont T., Kaeser S., Schaefer C., Kilger E., Neuenschwander A., Abramowski D., Frey P., Jaton A.L., Vigouret J.M., Paganetti P., Walsh D.M., Mathews P.M., Ghiso J., Staufenbiel M., Walker L.C., Jucker M. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 2006, 313:1781-1784.
5. Eisele Y.S., Bolmont T., Heikenwalder M., Langer F., Jacobson L.H., Yan Z.X., Roth K., Aguzzi A., Staufenbiel M., Walker L.C., Jucker M. Induction of cerebral β-amyloidosis: intracerebral versus systemic Aβ inoculation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12926-12931.
6. Ono K., Takahashi R., Ikeda T., Yamada M. Cross-seeding effects of amyloid β-protein and α-synuclein. J. Neurochem. 2012, 122:883-890.
7. O'Nuallain B., Williams A.D., Westermark P., Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 2004, 279:17490-17499.
8. Yagi H., Kusaka E., Hongo K., Mizobata T., Kawata Y. Amyloid fibril formation of α-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases. J. Biol. Chem. 2005, 280:38609-38616.
9. Waxman E.A., Giasson B.I. Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J. Neurosci. 2011, 31:7604-7618.
10. Johan K., Westermark G., Engstrom U., Gustavsson A., Hultman P., Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2558-2563.
11. Kunz C., Lonnerdal B. Human-milk proteins: analysis of casein and casein subunits by anion-exchange chromatography, gel electrophoresis, and specific staining methods. Am. J. Clin. Nutr. 1990, 51:37-46.
12. Thorn D.C., Ecroyd H., Sunde M., Poon S., Carver J.A. Amyloid fibril formation by bovine milk αs2-casein occurs under physiological conditions yet is prevented by its natural counterpart, αs1-casein. Biochemistry 2008, 47:3926-3936.
13. Zhang X., Tsukada M., Morikawa H., Aojima K., Zhang G., Miura M. Production of silk sericin/silk fibroin blend nanofibers. Nanoscale Res. Lett. 2011, 6:510.
14. Padamwar M.N., Pawar A.P., Daithankar A.V., Mahadik K.R. Silk sericin as a moisturizer: an in vivo study. J. Cosmet. Dermatol. 2005, 4:250-257.
15. Li G., Zhou P., Shao Z., Xie X., Chen X., Wang H., Chunyu L., Yu T. The natural silk spinning process. A nucleation-dependent aggregation mechanism?. Eur. J. Biochem. 2001, 268:6600-6606.
16. Pollard T.D., Blanchoin L., Mullins R.D. Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. Annu. Rev. Biophys. Biomol. Struct. 2000, 29:545-576.
17. Povarova O.I., Kuznetsova I.M., Turoverov K.K. Physical-chemical properties of actin in different structural states. New ideas about its folding-unfolding pathways. Tsitologiia 2005, 47:953-977.
18. Westermark P., Andersson A., Westermark G.T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 2011, 91:795-826.
19. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 2003, 87:172-181.
20. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6:277-293.
21. Johnson B.A. Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol. 2004, 278:313-352.
22. Lo K.W., Naisbitt S., Fan J.S., Sheng M., Zhang M. The 8-kDa dynein light chain binds to its targets via a conserved (K/R)XTQT motif. J. Biol. Chem. 2001, 276:14059-14066.
23. Vivekanandan S., Brender J.R., Lee S.Y., Ramamoorthy A. A partially folded structure of amyloid-β(1-40) in an aqueous environment. Biochem. Biophys. Res. Commun. 2011, 411:312-316.
24. LeVine H. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309:274-284.
25. Ono K., Condron M.M., Ho L., Wang J., Zhao W., Pasinetti G.M., Teplow D.B. Effects of grape seed-derived polyphenols on amyloid β-protein self-assembly and cytotoxicity. J. Biol. Chem. 2008, 283:32176-32187.
26. Fawzi N.L., Ying J., Torchia D.A., Clore G.M. Kinetics of amyloid β monomer-to-oligomer exchange by NMR relaxation. J. Am. Chem. Soc. 2010, 132:9948-9951.
27. Hou L., Shao H., Zhang Y., Li H., Menon N.K., Neuhaus E.B., Brewer J.M., Byeon I.J., Ray D.G., Vitek M.P., Iwashita T., Makula R.A., Przybyla A.B., Zagorski M.G. Solution NMR studies of the Aβ(1-40) and Aβ(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J. Am. Chem. Soc. 2004, 126:1992-2005.
28. Hasegawa K., Yamaguchi I., Omata S., Gejyo F., Naiki H. Interaction between Aβ(1-42) and Aβ(1-40) in Alzheimer's β-amyloid fibril formation in vitro. Biochemistry 1999, 38:15514-15521.
29. Wood S.J., Wetzel R., Martin J.D., Hurle M.R. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4. Biochemistry 1995, 34:724-730.
30. McLaurin J., Fraser P.E. Effect of amino-acid substitutions on Alzheimer's amyloid-β peptide-glycosaminoglycan interactions. Eur. J. Biochem. 2000, 267:6353-6361.
31. Snow A.D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W.A., Morgan D.G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron 1994, 12:219-234.
32. Giulian D., Haverkamp L.J., Yu J., Karshin W., Tom D., Li J., Kazanskaia A., Kirkpatrick J., Roher A.E. The HHQK domain of β-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J. Biol. Chem. 1998, 273:29719-29726.
33. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Bjorklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14:501-503.
34. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 2008, 14:504-506.
35. Munch C., O'Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3548-3553.
36. Ren P.H., Lauckner J.E., Kachirskaia I., Heuser J.E., Melki R., Kopito R.R. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol. 2009, 11:219-225.
37. Westermark G.T., Westermark P. Prion-like aggregates: infectious agents in human disease. Trends Mol. Med. 2010, 16:501-507.
38. Preusser M., Strobel T., Gelpi E., Eiler M., Broessner G., Schmutzhard E., Budka H. Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting. J. Neurol. Neurosurg. Psychiatry 2006, 77:413-416.
39. Yamada M., Tsukagoshi H., Otomo E., Hayakawa M. Systemic amyloid deposition in old age and dementia of Alzheimer type: the relationship of brain amyloid to other amyloid. Acta Neuropathol. 1988, 77:136-141.
40. Cherny I., Gazit E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed. Engl. 2008, 47:4062-4069.
41. Knowles T.P., Buehler M.J. Nanomechanics of functional and pathological amyloid materials. Nat. Nanotechnol. 2011, 6:469-479.